Medical News Today: Hormone replacement therapy may increase risk of hearing loss
A new, first-of-its-kind study investigates the link between hormone replacement therapy and hearing loss in menopausal and postmenopausal women.
Abstract: With life expectancy increasing, women will spend one-third of their lives in and beyond menopause. A collaborative discussion with the clinician facilitates informed decision-making and should include evidence-based discussion of physiologic changes, assessment of symptoms and treatment options, review of screening recommendations, and discussion of disease risk-reduction strategies and psychosocial issues.
Neuroscientist David Eagleman talks about time perception, synesthesia, and the vastness of human creativity.Medscape Neurology
[Daily Maverick] "There is really no such thing as the 'voiceless'. There are only the deliberately silenced, or the preferably unheard." The words of Arundhati Roy, a writer turned human rights activist, rang particularly true through the course of the Life Esidimeni saga. The 118 deceased residents who have now risen to 141 were the preferably unheard - their cries for help through pressure sores and other unaccounted wounds, signs of starvation and dehydration, all fell on deaf ears. However, it is only in retrospect we
Research published inMenopause reports that women who stop hormone therapy after menopause are at higher risk of cardiac and stroke death.Healio
Background: The World Health Organization recommends benzylpenicillin and gentamicin as antimicrobial treatment for infants with sepsis in low-income settings, and ceftriaxone or cefotaxime as an alternative. In a meta-analysis from 13 low-income settings, Staphylococcus aureus, Klebsiella spp. and Escherichia coli accounted for 55% of infants with sepsis. In a review of bacterial meningitis, resistance to third generation cephalosporins was>50% of all isolates, and 44% of Gram-negative isolates were gentamicin resistant. However, ceftriaxone may cause neonatal jaundice, and gentamicin may cause deafness. Therefore, w...
With a clinical trial underway to restore vision optogenetically, researchers also see promise in using the technique to treat deafness, pain, and other conditions.
(The North American Menopause Society (NAMS)) There is no doubt the prevalence of obesity has increased significantly across all age groups, creating greater health risks. What exactly constitutes obesity, however, is subject to debate, especially for postmenopausal women who have a different body composition than younger women. A study published online today in Menopause, the journal of The North American Menopause Society (NAMS), demonstrates that the long-accepted BMI definition for obesity may no longer be accurate.
This study provides valuable insight into human health risk assessment regarding PFHxS exposure. PMID: 29143853 [PubMed - as supplied by publisher]
Menopause can be a time of change for women and may be marked by disturbances in mood. For women living with a mental illness, such as bipolar disorder, little is known about how they experience mood changes d...
AbstractThe changing hormonal milieu during the menopausal transition may contribute to the development of memory disorders. We aimed to assess the association of sex hormones with memory function in a sample of Greek middle-aged women. This pilot study included 44 women with subjective memory complaints. Memory performance was evaluated using the Hopkins Verbal Learning Test (HVLT), the Brief Visuospatial Memory test (BVMT), and the verbal digits backwards test (VSPAN), to assess verbal, visuospatial, and working memory performance, respectively. Menopausal symptoms were assessed using the Green Climacteric Scale. VSPAN b...